Skip to content

Comparisons of the clinical outcomes of Centurion® active fluidics system with a low IOP setting and Signature Pro® gravity fluidics system with a normal IOP setting for cataract patients with high myopia

Comparisons of the clinical outcomes of Centurion® active fluidics system with a low IOP setting and Signature Pro® gravity fluidics system with a normal IOP setting for cataract patients with high myopia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400080875
Enrollment
Unknown
Registered
2024-02-12
Start date
2024-03-01
Completion date
Unknown
Last updated
2024-02-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cataract

Interventions

Centurion Group:Use Centurion phacoemulsification platform during surgery
Signature Pro Group:Use Signature Pro phacoemulsification platform during surgery

Sponsors

Peking University Third Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1) Patients aged 40-85 years with age-related cataracts 2) Eye axis >26mm, ECD>2000/mm2, ACD>2.5mm 3) The nucleus of the lens is graded 2-3 according to the Lens Opacities Classification System (version III, LOCS III), 4) To implant the Alcon AcrySof intraocular lens 5) Can move freely and cooperate with the examination 6) Willing to sign or guardian sign informed consent and can complete the follow-up

Exclusion criteria

Exclusion criteria: 1) History of internal eye surgery 2) Irregular corneal astigmatism 4) Pupil diameter <6mm after mydriasis before surgery 5) Associated with certain eye diseases, including but not limited to: macular degeneration, retinal detachment, uveitis, glaucoma, central corneal opacity, intraocular implants (such as ICL, silicone oil) 6) Systemic connective tissue disease 7) Not yet under control or serious systemic chronic diseases such as heart and brain diseases, diabetes, etc 8) Unable to complete full follow-up

Design outcomes

Primary

MeasureTime frame
Increase rate of macular thickness;

Secondary

MeasureTime frame
Para-macular vesicular density;Visual acuity;intraocular pressure, IOP;optometry;slit-lamp examination;corneal endothelial cell density;central corneal thickness;corneal astigmatism;

Countries

China

Contacts

Public ContactXiaoyong Chen

Peking University Third Hospital

dr_chxy@163.com+86 156 1196 8041

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026